Use of a novel eimeria gene and corresponding protein

Details for Australian Patent Application No. 2004255594 (hide)

Owner Bayer Animal Health GmbH

Inventors Krucken, Jurgen; Greif, Gisela; Wunderlich, Frank; Hosse, Ralf

Agent Davies Collison Cave

Pub. Number AU-B-2004255594

PCT Pub. Number WO2005/005472

Priority 103 30 235.2 04.07.03 DE

Filing date 30 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 9 December 2010

International Classifications

C07K 14/455 (2006.01) Peptides having more than 20 amino acids

A61K 39/012 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/20 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/005472 Priority application(s): WO2005/005472

13 August 2009 Assignment before Grant

  Bayer HealthCare Aktiengesellschaft The application has been assigned to Bayer Animal Health GmbH

9 December 2010 Application Accepted

  Published as AU-B-2004255594

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255602-Multi-layered product with a coextruded side which can be recognised more easily

2004255586-Resin and ink for the printing of shrink sleeves